These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 27019141)

  • 21. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.
    Bartel SB; Tyler TG; Power LA
    Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.
    Quartucci C; Rooney JPK; Nowak D; Rakete S
    Int Arch Occup Environ Health; 2023 Jul; 96(5):675-683. PubMed ID: 36877242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A surface wipe sampling and LC-MS/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers.
    Jeronimo M; Colombo M; Astrakianakis G; Hon CY
    Anal Bioanal Chem; 2015 Sep; 407(23):7083-92. PubMed ID: 26141324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy Safe Handling: Limiting Nursing Exposure With a Hazardous Drug Control Program.
    Crickman R
    Clin J Oncol Nurs; 2017 Feb; 21(1):73-78. PubMed ID: 28107320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring extent of surface contamination produced by the handling of antineoplastic drugs in low- to middle-income country oncology health care settings.
    Müller-Ramírez C; Squibb K; McDiarmid M
    Arch Environ Occup Health; 2017 Sep; 72(5):289-298. PubMed ID: 27603111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs).
    Dugheri S; Mucci N; Bucaletti E; Squillaci D; Cappelli G; Trevisani L; Bonari A; Cecchi M; Mini E; Ghiori A; Tognoni D; Berti N; Alderighi F; Li Vigni N; Orlandi I; Arcangeli G
    Med Pr; 2022 Dec; 73(5):383-396. PubMed ID: 36374172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of a decontamination procedure in a pharmacy buffer room contaminated by 5 antineoplastic agents.
    Arpino P; Yeomelakis J; Oommen A
    Am J Health Syst Pharm; 2020 Dec; 77(24):2081-2088. PubMed ID: 33150407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occupational exposure to cytotoxic drugs: the importance of surface cleaning to prevent or minimise exposure.
    Viegas S; Oliveira AC; Carolino E; Pádua M
    Arh Hig Rada Toksikol; 2018 Sep; 69(3):238-249. PubMed ID: 30285944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents.
    Queruau Lamerie T; Nussbaumer S; Décaudin B; Fleury-Souverain S; Goossens JF; Bonnabry P; Odou P
    Ann Occup Hyg; 2013 May; 57(4):456-69. PubMed ID: 23223271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches in safe handling of hazardous drugs.
    ONS News; 2004; 19(9 Suppl):31-2. PubMed ID: 15478576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermal exposure assessment techniques.
    Fenske RA
    Ann Occup Hyg; 1993 Dec; 37(6):687-706. PubMed ID: 8304685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical strategies for assessing occupational exposure to antineoplastic drugs in healthcare workplaces.
    Dugheri S; Bonari A; Pompilio I; Boccalon P; Tognoni D; Cecchi M; Ughi M; Mucci N; Arcangeli G
    Med Pr; 2018 Dec; 69(6):589-604. PubMed ID: 30489549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Measurement Methods for Dermal Exposure to Hazardous Chemicals at the Workplace: The SysDEA Project.
    Kasiotis KM; Spaan S; Tsakirakis AN; Franken R; Chartzala I; Anastasiadou P; Machera K; Rother D; Roitzsch M; Poppek U; Lucadei G; Baumgärtel A; Schlüter U; Gerritsen-Ebben RM
    Ann Work Expo Health; 2020 Jan; 64(1):55-70. PubMed ID: 31785203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.
    Kopp B; Schierl R; Nowak D
    Int Arch Occup Environ Health; 2013 Jan; 86(1):47-55. PubMed ID: 22311009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2021; 25(6):515-522. PubMed ID: 34807847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2022; 26(1):72-79. PubMed ID: 35081047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs.
    Dillon LR
    Int J Pharm Compd; 2020; 24(1):30-36. PubMed ID: 32023214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing wipe sampling strategy guidance for assessing environmental contamination of antineoplastic drugs.
    Arnold S; Jeronimo M; Astrakianakis G; Kunz M; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Davies HW
    J Oncol Pharm Pract; 2023 Dec; 29(8):1816-1824. PubMed ID: 35924415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.